|
RNF167 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29849999641607E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67239999521374E-08 |
| Normal-vs-Stage2 |
6.364600E-01 |
| Normal-vs-Stage3 |
3.7545999975741E-08 |
| Normal-vs-Stage4 |
2.38020000042916E-07 |
| Stage1-vs-Stage2 |
4.442600E-04 |
| Stage1-vs-Stage3 |
2.056200E-01 |
| Stage1-vs-Stage4 |
1.755650E-01 |
| Stage2-vs-Stage3 |
2.005800E-04 |
| Stage2-vs-Stage4 |
1.969840E-04 |
| Stage3-vs-Stage4 |
7.558200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18910004065498E-09 |
| Normal-vs-AfricanAmerican |
1.561670E-04 |
| Normal-vs-Asian |
8.011600E-04 |
| Caucasian-vs-AfricanAmerican |
9.716800E-01 |
| Caucasian-vs-Asian |
3.206400E-01 |
| AfricanAmerican-vs-Asian |
5.199400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.25450000004945E-06 |
| Normal-vs-Female |
2.10239999853812E-08 |
| Male-vs-Female |
9.977200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.78190000532652E-08 |
| Normal-vs-Age(41-60Yrs) |
3.3699000001608E-07 |
| Normal-vs-Age(61-80Yrs) |
1.186210E-04 |
| Normal-vs-Age(81-100Yrs) |
5.572100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.382600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.518600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.198200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.551400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.390400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.077200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.58039999975657E-07 |
| Classical-VS-Follicular |
8.180800E-04 |
| Classical-VS-Other |
9.330000E-01 |
| Classical-VS-Normal |
3.45170003690498E-09 |
| Tall-VS-Follicular |
3.6247005397172E-10 |
| Tall-VS-Other |
9.036100E-02 |
| Tall-VS-Normal |
1.63125069008174E-12 |
| Follicular-VS-Other |
3.187200E-01 |
| Follicular-VS-Normal |
3.291200E-01 |
| Other-VS-Normal |
1.876440E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.214000E-04 |
| Normal-vs-N1 |
1.14529996597668E-09 |
| N0-vs-N1 |
1.226260E-04 |
|
|
